1. Home
  2. KFY vs HROW Comparison

KFY vs HROW Comparison

Compare KFY & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KFY
  • HROW
  • Stock Information
  • Founded
  • KFY 1969
  • HROW 1998
  • Country
  • KFY United States
  • HROW United States
  • Employees
  • KFY 10697
  • HROW N/A
  • Industry
  • KFY Diversified Commercial Services
  • HROW Biotechnology: Pharmaceutical Preparations
  • Sector
  • KFY Consumer Discretionary
  • HROW Health Care
  • Exchange
  • KFY Nasdaq
  • HROW Nasdaq
  • Market Cap
  • KFY 3.6B
  • HROW 1.1B
  • IPO Year
  • KFY 1999
  • HROW N/A
  • Fundamental
  • Price
  • KFY $67.44
  • HROW $31.11
  • Analyst Decision
  • KFY Buy
  • HROW Strong Buy
  • Analyst Count
  • KFY 3
  • HROW 6
  • Target Price
  • KFY $77.67
  • HROW $59.00
  • AVG Volume (30 Days)
  • KFY 291.1K
  • HROW 449.0K
  • Earning Date
  • KFY 06-18-2025
  • HROW 08-06-2025
  • Dividend Yield
  • KFY 2.79%
  • HROW N/A
  • EPS Growth
  • KFY 60.40
  • HROW N/A
  • EPS
  • KFY 4.63
  • HROW N/A
  • Revenue
  • KFY $2,708,840,000.00
  • HROW $212,858,000.00
  • Revenue This Year
  • KFY N/A
  • HROW $44.19
  • Revenue Next Year
  • KFY $2.12
  • HROW $39.09
  • P/E Ratio
  • KFY $14.85
  • HROW N/A
  • Revenue Growth
  • KFY N/A
  • HROW 53.49
  • 52 Week Low
  • KFY $59.23
  • HROW $16.87
  • 52 Week High
  • KFY $80.64
  • HROW $59.23
  • Technical
  • Relative Strength Index (RSI)
  • KFY 48.57
  • HROW 63.19
  • Support Level
  • KFY $69.42
  • HROW $27.76
  • Resistance Level
  • KFY $71.14
  • HROW $32.45
  • Average True Range (ATR)
  • KFY 1.19
  • HROW 1.47
  • MACD
  • KFY -0.22
  • HROW 0.25
  • Stochastic Oscillator
  • KFY 17.63
  • HROW 76.91

About KFY Korn Ferry

Korn Ferry is a United States-based firm engaged in organizational consulting and management recruitment that helps clients fill mid- to high-level management positions. The company's segment includes Consulting; Digital; Executive Search; Professional Search & Interim; and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The consulting segment aligns organizational structure, culture, performance, development, and people to drive sustainable growth by addressing four fundamental organizational and talent needs. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: